INTRODUCTION {#s0}
============

The active elimination of competing microorganisms is primordial in the fight for ecologic space. Bacteriocins are secreted protein antibiotics that act as key mediators of antagonistic interactions between bacteria ([@B1], [@B2]). Studies in the Gram-negative model organisms *Escherichia coli* and *Pseudomonas aeruginosa* have identified compounds very diverse in molecular size, ranging from small peptides (e.g., microcins) to modular multidomain proteins (e.g., colicins, S-type pyocins) and large multiprotein complexes resembling bacteriophage tails (tailocins) ([@B3][@B4][@B6]). Bacteriocins usually only kill close phylogenetic relatives, typically belonging to the same species or genus ([@B2], [@B7]). These allelopathic molecules are currently receiving renewed interest for combating multidrug-resistant pathogens, mainly in the framework of food and medical applications ([@B8][@B9][@B13]). Their high efficacy and selectivity, natural presence in the environment, biodegradability, and nonreplicative behavior (compared to phages, in the case of tailocins) make them attractive drug leads.

Pseudomonads are prominent producers of both ribosomally and nonribosomally synthesized antibacterial molecules. Their genome plasticity has enabled them to acquire a diversified bacteriocin arsenal ([@B5], [@B14]), facilitating colonization of different environments, such as rhizospheres and lungs ([@B15][@B16][@B18]). Lectin-like bacteriocins, also called LlpAs, are midsize bacteriotoxins (\~28 kDa) that lack an enzymatic or pore-forming toxin-immunity pair characteristic for modular bacteriocins and other polymorphic toxins ([@B4], [@B5], [@B19], [@B20]). They adopt an architecture comprising tandem B-lectin domains followed by a short nonconserved carboxy-terminal extension ([@B21], [@B22]). Compared to B-lectins from plants, the affinity of *Pseudomonas* LlpAs for [d]{.smallcaps}-mannose is low, reflecting a much higher affinity of the bacteriocin for [d]{.smallcaps}-rhamnose ([@B22]), a 6-deoxy-mannose that is omnipresent in the common polysaccharide antigen (CPA) of *Pseudomonas* lipopolysaccharide (LPS) ([@B23]). No association between LlpA selectivity and O serotype of target cells could be detected for lectin-like bacteriocins from *Pseudomonas aeruginosa* (also designated [l]{.smallcaps}-type pyocins) ([@B24]). CPA binding capacity is hosted by the carboxy-terminal lectin domain; however, lack of LPS binding is not sufficient for provoking full LlpA resistance toward susceptible strains ([@B22]). Via the construction of engineered LlpA chimeras, strain selectivity of killing by LlpAs was attributed to the amino-terminal lectin domain ([@B21]).

Here, we identify the essential outer membrane protein insertase BamA as the major selectivity determinant of LlpA susceptibility in *Pseudomonas* spp. We show that LlpA-resistant mutants arise by mutations in a particular surface-exposed hypervariable loop of BamA, and we link LlpA-selective killing to amino acid sequence polymorphisms in this BamA loop.

RESULTS {#s1}
=======

LPS binding by LlpA cannot fully account for the bacteriocin's strain-specific lethality. Given that CPA-deficient mutant strains display a (partial) bacteriocin-inhibited phenotype ([@B22]), we anticipated that additional factors must contribute to the toxin's selective action. To identify such determinants, LlpA-resistant mutants of a bacteriocin-susceptible *Pseudomonas* strain were isolated, arising as colonies within halos produced by spotting concentrated bacteriocin onto a lawn of late-stationary-phase cells. *Pseudomonas fluorescens* Pf0-1 was chosen as an indicator. This strain is highly susceptible to recombinant LlpA1 from the biocontrol model strain *Pseudomonas protegens* Pf-5 ([@B25], [@B26]) and its genome has been completely sequenced ([@B27]), facilitating single nucleotide polymorphism (SNP) analysis. A single colony was selected from each of four independent treatments/halos (mutants B1 to B4). In a fifth independent exposure experiment, two slightly different morphotypes could be distinguished (mutants B5a and B5b). After validation of resistance toward LlpA1, the parental origin of the mutants was confirmed via BOX-PCR. The genomes of these six mutants and the Pf0-1 wild type were sequenced and analyzed for SNPs ([Table 1](#tab1){ref-type="table"}; [Fig. 1](#fig1){ref-type="fig"}).

###### 

SNPs detected in LlpA1-resistant *P. fluorescens* Pf0-1 mutants[^a^](#ngtab1.1){ref-type="table-fn"}

  -----------------------------------------------------------------------------------------------------------------------------------
  Mutant   Mutation\   Coding region\                                                      Amino acid\   Gene               Protein
           type        change                                                              change                           
  -------- ----------- ------------------------------------------------------------------- ------------- ------------------ ---------
  B1       SNV         [ABA77421.1](https://www.ncbi.nlm.nih.gov/protein/ABA77421%2e1),\   Gln106\*      *pfl01_RS28605*\   Wzt
                       316 C → T                                                                         (pfl01_5685)       

  B2       SNV         [ABA72852.1](https://www.ncbi.nlm.nih.gov/protein/ABA72852%2e1),\   Gly667Val     *pfl01_RS05600*\   BamA
                       2000 G → T                                                                        (pfl01_1109)       

  B3       Ins         [ABA72221.1](https://www.ncbi.nlm.nih.gov/protein/ABA72221%2e1),\   Gly286Fs      *pfl01_RS02405*\   FuzY
                       857_858 InsC                                                                      (pfl01_0477)       

  B4       SNV         [ABA72852.1](https://www.ncbi.nlm.nih.gov/protein/ABA72852%2e1),\   Thr671Ala     *pfl01_RS05600*\   BamA
                       2011 A → G                                                                        (pfl01_1109)       

  B5a      SNV         [ABA72852.1](https://www.ncbi.nlm.nih.gov/protein/ABA72852%2e1),\   Arg666Cys     *pfl01_RS05600*\   BamA
                       1996 C → T                                                                        (pfl01_1109)       

  B5b      SNV         [ABA72852.1](https://www.ncbi.nlm.nih.gov/protein/ABA72852%2e1),\   Arg666Cys     *pfl01_RS05600*\   BamA
                       1996 C → T                                                                        (pfl01_1109)       

           Δ           [ABA77417.1](https://www.ncbi.nlm.nih.gov/protein/ABA77417%2e1),\   Lys2Fs        *pfl01_RS28585*\   Rmd
                       4 ΔA                                                                              (pfl01_5681)       
  -----------------------------------------------------------------------------------------------------------------------------------

Abbreviations and symbols: Δ, deletion; Fs, frameshift; Ins, insertion; SNV, single nucleotide variation. An asterisk specifies the introduction of a stop codon.

![Schematic representation of BamAs from *P. fluorescens* Pf0-1 and *P. aeruginosa* PAO1, which are susceptible to LlpA1 and PyoL1, respectively, and the detected SNPs in bacteriocin-resistant mutants. Conserved surface-exposed residues in the respective *Pseudomonas* species are colored gray, and surface-exposed polymorphic residues of L6 in *P. fluorescens* and *P. aeruginosa* strains are black. Mutations identified by whole-genome sequencing are highlighted in orange, and others are pink. Amino acid deletions are shown as empty ovals. N and C specify the amino- and carboxy-terminal ends, respectively.](mbo0021837710001){#fig1}

Escape from LlpA1 killing by mutations in LPS genes. {#s1.1}
----------------------------------------------------

Whereas the Pf0-1 parent did not contain any mutation compared to the reference genome, the spontaneous mutants all contained one SNP, except for B5b. Three of the mutations observed (in mutants B1, B3, and B5b) were directly linked to LPS biosynthesis. In B1 and B5b, mutations were found in *pfl01_5685* (nonsense mutation) and *pfl01_5681* (frameshift), which encode orthologues of Wzt and Rmd from *P. aeruginosa* PAO1, respectively (82.2% amino acid identity to PA5450 and 73.6% amino acid identity to PA5454). These Pf0-1 genes are part of an LPS biosynthetic gene cluster that is syntenic to the CPA biosynthetic cluster of *P. aeruginosa* PAO1 (*rmd-gmd-wbpW-wzm-wzt-wbpX-wbpY-wbpZ*) ([@B23]). Mutations in several of these genes (*wzm*, *wzt*, and *wbpZ*) confer high tolerance to the *P. aeruginosa* PAO1-specific LlpA, pyocin L1 (PyoL1), due to lack of CPA assembly and, consequently, absence of the appropriate [d]{.smallcaps}-rhamnose-carrying LPS moiety recognized by LlpA's C-terminal domain ([@B22]). This extends the role of CPA in LlpA binding onto LPS, as demonstrated for *P. aeruginosa* and *Pseudomonas syringae* ([@B22]), to a third phylogenetic group of pseudomonads.

The other mutants are affected in genes that were previously not linked to LlpA function. In B3 cells, a frameshift mutation occurred in *pfl01_0477*, specifying a putative glycosyl transferase homologous to FuzY (70% amino acid identity) encoded by the *fuzVWXYZ* operon that accounts for the fuzzy spreader phenotype of *P. fluorescens* SBW25 and is predicted to modify LPS O antigens (see [Fig. S1](#figS1){ref-type="supplementary-material"} in the supplemental material) ([@B28]). A *fuz*-like operon is present in *P. fluorescens* Pf0-1; however, it has an additional glycosyl transferase gene (*pfl01_0474*) located between the *fuzV* and *fuzW* homologues. The morphotype resulting from a *fuzY* mutation provokes a highly aggregative phenotype in strain SBW25, which was also evident for the B3 mutant, based on rapid sedimentation of planktonic cells. The exact function of FuzY remains elusive to date. Partly similar clusters can be detected in *Pseudomonas syringae* and *Pseudomonas aeruginosa* strains, although an equivalent of *pfl01_0477* is consistently lacking. An extra gene involved in the fuzzy spreader phenotype and associated with a partially similar cluster was detected in *P. syringae* pv. *actinidiae* ICMP 18884 ([Fig. S1](#figS1){ref-type="supplementary-material"}) ([@B29]). Together, these findings suggest that the carbohydrate binding by LlpAs may involve accessory moieties in addition to [d]{.smallcaps}-rhamnose, and they hint at subtle differences in LlpA-LPS interactions that depend on the particular bacteriocin-target strain combination. In general, the affinity of lectins for oligomeric carbohydrates is higher than that for monomers ([@B30]). Similarly, secondary LPS carbohydrate binding by LlpA might strengthen the interaction and ensure optimal positioning of LlpA close to other surface constituents.
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Genetic organization of the *fuzVWXYZ* locus in the genome of *P. fluorescens* SBW25 in comparison with corresponding regions in *P. aeruginosa* PAO1, *P. fluorescens* Pf0-1 and *P. syringae* pv. *syringae* ICMP 18884. Synteny is visualized by sequence conservation (grey shading) for the corresponding orthologues, if present. Genes (displayed as arrows) of the *fuzVWXYZ* cluster in *P. fluorescens* SBW25 are colored blue and an extra gene involved in the fuzzy spreader phenotype in *P. syringae* pv. *syringae* ICMP 18884 is shown in yellow. The location of the *fuzY* mutation (insertion) in *P. fluorescens* Pf0-1 mutant B3 (red) is indicated with a black triangle. Dotted lines indicate the absence of an equivalent sequence. Download FIG S1, TIF file, 0.2 MB.
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LlpA-resistant mutants carry a modified surface loop in BamA. {#s1.2}
-------------------------------------------------------------

The non-LPS mutants (B2, B4, and B5a/B5b \[identical transition in B5a and B5b\]) all carried missense mutations in *pfl01_1109*, which encodes the essential β-barrel membrane protein BamA ([Fig. 1](#fig1){ref-type="fig"}; [Table 1](#tab1){ref-type="table"}). In mutant B5b, this was accompanied by the aforementioned *rmd* mutation, which affected CPA metabolism. BamA, together with the lipoproteins BamB, BamC, BamD, and BamE, constitutes the BAM complex that ensures the integration and folding of proteins in the outer membrane via a mechanism requiring a lateral gate and exit pore formation ([@B31][@B32][@B34]). Pfl01_1109 includes four POTRA domains (*po*lypeptide *tr*ansport *a*ssociated; Pfam [PF07244](http://pfam.xfam.org/family/PF07244)) and a characteristic conserved VRGF motif in the β-barrel ([@B35]). A fifth POTRA domain that is typically present in BamAs from proteobacteria ([@B33], [@B36]) was not detected in the \~70-amino-acid amino-terminal region of mature Pfl01_1109. Distinct BamA crystal structures from *Neisseria meningitidis*, *Haemophilus ducreyi*, and *Escherichia coli* have been solved ([@B37][@B38][@B40]) and revealed dome-like structures exposed to the extracellular surface, essentially consisting of three large loops, termed loops 4, 6, and 7 (further abbreviated L4, L6, and L7, respectively), that are stabilized by a salt bridge network ([@B41]). The BamA mutations that were retrieved in the LlpA1-resistant Pf0-1 mutants could all be localized to L6 (B2, B4, and B5a/b) ([Fig. 1](#fig1){ref-type="fig"}), suggesting L6 as a candidate interaction hot spot in the potential susceptibility determinant BamA. The BamA barrel sequences of an additional set of 10 mutants isolated from halos of independent Pf0-1 cultures were determined, and 2 of these mutants carried BamA mutations as well: T663P and G540D ([Fig. 1](#fig1){ref-type="fig"}). The former mutation is located in the predicted surface-exposed L6 loop of BamA~Pf0−1~, whereas G540 is part of L4 and positioned near L6 and possibly assists in its stabilization (based on the structural prediction) ([Fig. 2](#fig2){ref-type="fig"}).

![Cartoon representation of homology models of BamA barrel domains from *P. fluorescens* Pf0-1 (A) and *P. aeruginosa* PAO1 (B). Residues composing surface-exposed loops L4, L6, and L7 are shown as spheres colored blue, red, and orange, respectively. G540 residues in the respective BamAs are yellow.](mbo0021837710002){#fig2}

To further explore this potential targeting of BamA by use of a different indicator strain-bacteriocin combination, a similar experimental setup was applied to *P. aeruginosa* PAO1, which is susceptible to PyoL1 of *P. aeruginosa* C1433 ([@B22], [@B24]), a lectin-like bacteriocin sharing only 32% amino acid identity with LlpA1. A set of spontaneous mutants growing inside halos was randomly selected (1 mutant per halo; 30 independent cultures), validated for altered PyoL1 susceptibility, and their β-barrel *bamA* gene fragments were sequenced. Isolates showing diminished halo sizes did not contain mutations in *bamA*, whereas fully resistant isolates (13/30) were all affected in residues of L6 or in close proximity to L6 ([Fig. 1](#fig1){ref-type="fig"}). In addition to the large set of L6 mutations, G540 was affected in several mutants ([Fig. 2](#fig2){ref-type="fig"}), as observed for the corresponding residue in Pf0-1, whereas no other mutations in the covered *bamA* barrel sequence could be retrieved. Originating from independent cultures, two mutations (G540V and G672C) were retrieved twice. Most likely, the subset of mutants without detectable *bamA* mutations includes strains affected in LPS metabolism, but this was not further investigated. This convergent genetic data set from independent analysis of two distinct bacteriocin-target combinations strongly suggests that, in addition to CPA, a surface-exposed epitope of BamA, including (part of) L6, functions as a key interaction partner for lectin-like bacteriocins on the surface of susceptible cells.

Heterologous expression of cognate BamA confers susceptibility to LlpA. {#s1.3}
-----------------------------------------------------------------------

Assuming that BamA acts as a LlpA bacteriocin target, one expects a strain to become resistant when deprived from its (cognate) *bamA* gene. To explore this hypothesis, the *bamA* insertase from a PAO1 deletion mutant---expressing its *bamA* gene from a plasmid to retain viability ([@B42])---was transformed with shuttle vector pJB3Tc20 encoding a *bamA* orthologue originating from strain *P. aeruginosa* Br670 ([@B43]). The latter strain is not killed by PyoL1 but instead is inhibited by PyoL2 ([@B24]). When supplemented with this second plasmid, the PAO1 deletion mutant was sensitive to both PyoL1 and PyoL2. Conversely, when cured from its original plasmid, PyoL1 susceptibility was completely abrogated and only PyoL2 susceptibility remained ([Fig. 3](#fig3){ref-type="fig"}). These phenotypic alterations point out that BamA indeed acts as a selective killing partner for LlpA, in line with the SNP analysis of resistant mutants and supporting the proposed selectivity hypothesis.

![Susceptibilities of *P. aeruginosa* PAO1 (wild-type and Δ*bamA*~PAO1~ background), heterologously expressing *bamA* genes from *P. aeruginosa* PAO1 or Br670, for lectin-like bacteriocins PyoL1 and PyoL2. Wild-type *P. aeruginosa* strains PAO1 and Br670 are killed by PyoL1 and PyoL2, respectively. Controls were plasmids without the insert. The presence of a halo is indicative of growth inhibition due to bacteriocin activity.](mbo0021837710003){#fig3}

To explore this further, *bamA* genes from *Pseudomonas* strains targeted by different LlpAs were expressed in select *Pseudomonas* host strains. In addition to the plasmid expressing *bamA*~*Br670*~, corresponding genes from *P. aeruginosa* PAO1, *P. fluorescens* Pf0-1, and *P. savastanoi* pv. *glycinea* LMG 5066, strains that are killed by PyoL1, LlpA1, and LlpA~BW11M1~, respectively ([@B22], [@B24][@B25][@B26]), were cloned in pJB3Tc20. *Pseudomonas* acceptor strains were chosen based on their established susceptibility for one of these bacteriocins. Spot assays revealed that PyoL1-susceptible *P. aeruginosa* strains equipped with a *bamA* originating from a PyoL2-targeted strain became fully sensitive to PyoL2 (as could be inferred from the plasmid exchange setup in the PAO1 deletion background), and vice versa ([Fig. S2](#figS2){ref-type="supplementary-material"}). Furthermore, when equipped with the *P. fluorescens* or *P. savastanoi bamA*, *P. aeruginosa* strains became susceptible to LlpA1 and LlpA~BW11M1~, respectively. As expected, when *bamA* genes were heterologously expressed, a mixed phenotype was obtained.
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Susceptibility of *Pseudomonas aeruginosa* strains, heterologously expressing *bamA* genes from different donors, to lectin-like bacteriocins PyoL1, PyoL2, LlpA1, and LlpA~BW11M1~. Controls are strains transformed with a wild-type plasmid (no insert). Sensitivity pairs: *P. aeruginosa* PAO1/PyoL1, *P. aeruginosa* Br670/PyoL2, *P. fluorescens* Pf0-1/LlpA1, *P. savastanoi* pv. *glycinea* LMG 5066/LlpA~BW11M1~. The presence of a halo is indicative of growth inhibition due to bacteriocin activity. Download FIG S2, TIF file, 1.4 MB.
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We also examined whether such *bamA*-triggered phenotypic conversion in bacteriocin susceptibility may occur in non-*P. aeruginosa* strains. *Pseudomonas lini* VA1.2 and *Pseudomonas brassicacearum* WCS365, both sensitive to LlpA~BW11M1~, could be sensitized to the other LlpAs ([Fig. S3](#figS3){ref-type="supplementary-material"}). L pyocin action was elicited in *Pseudomonas migulae* ZA 45.2, a strain killed by LlpA1 and LlpA ([@B26]), when it expressed the respective *P. aeruginosa bamA* genes. For other strains (mainly) originating from the *P. fluorescens* species group, the bacteriocin phenotype switch was not always conclusive. For example, *Pseudomonas fluorescens* LMG 1794, which is killed by LlpA1, can only be (partially) sensitized to LlpA~BW11M1~. It should be emphasized that this strain (as well as some other *P. fluorescens* strains) does not host a (complete) CPA cluster in its genome ([@B44]), which may impact LPS-mediated LlpA docking. Another possible reason is that the heterologously expressed *bamA* is not fully compatible with the BAM machinery of the host strain, given the intimate character of its different accessory partners ([@B31], [@B45]).

10.1128/mBio.02138-17.3

Susceptibility of *Pseudomonas* strains (non *P. aeruginosa*), heterologously expressing *bamA* genes from different donors, to lectin-like bacteriocins PyoL1, PyoL2, LlpA1, and LlpA~BW11M1~. Controls are strains transformed with a wild-type plasmid (no insert). Sensitivity pairs: *P. aeruginosa* PAO1/PyoL1, *P. aeruginosa* Br670/PyoL2, *P. fluorescens* Pf0-1/LlpA1, *P. savastanoi* pv. *glycinea* LMG 5066/LlpA~BW11M1~. The presence of a halo is indicative of growth inhibition due to bacteriocin activity. Download FIG S3, TIF file, 1.6 MB.
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*Pseudomonas* BamA polymorphism is confined to surface-exposed loops. {#s1.4}
---------------------------------------------------------------------

Given the observations that BamA was key to LlpA selectivity and that BamA mutations resulting in LlpA resistance were mainly retrieved in the surface-exposed L6 loop, sequence polymorphism of BamA in *Pseudomonas* was further dissected. Representatives from *Pseudomonas* with abundant genome information (*P. aeruginosa*, *P. fluorescens*, *P. putida*, and *P. syringae*) were selected for further analysis. Considering that species delineation within pseudomonads is blurry, species groups were considered for *P. fluorescens*, *P. putida*, and *P. syringae* ([@B46], [@B47]). An interesting observation is that a number of pseudomonads encode a second BamA, likely resulting from a recent duplication event ([@B36]). *P. aeruginosa* consistently hosts one *bamA*, whereas strains with a second *bamA* are occasionally found in *P. fluorescens* and *P. putida* species groups and to a lesser extent in *P. syringae*. Strains previously used as *bamA* donors (Br670, LMG 5066, PAO1, and Pf0-1) only encode one *bamA*, and in our analysis only the ubiquitous gene located between Zn metalloprotease gene *rseP* and periplasmic chaperone gene *hlpA* (*skp* in *E. coli*) was considered.

At the species (group) level, BamA polymorphism is essentially confined to loops L4, L6, and L7. Variations may equally occur in the β-barrel sequences but are only present at relevant frequencies in BamAs from the polyphyletic *P. fluorescens* and *P. putida* groups ([Fig. 4](#fig4){ref-type="fig"}). Polymorphism is restricted to only part of the surface-exposed moieties, although the extent to which this can be observed largely depends on the species (group) of interest. All pseudomonads display polymorphism in L6, with certain loop sequence variants occurring more frequently. L4 and L7 show different levels of polymorphism: the *P. aeruginosa* and the *P. syringae* groups display good conservation in L4 (but the latter to a lesser extent); conservation in L7 is only high for *P. aeruginosa*. In general, the hypervariable part of L4 is rather small and limited to 8 to 9 residues, with (virtually) all *Pseudomonas* isolates sharing a central EGD triplet. In L7, two conserved cysteines consistently arise, suggesting the formation of a disulfide bridge, as observed in different crystal structures from *E. coli* BamA ([@B37], [@B40]). There also appears to be no strict coupling of different loops for any of the species groups, i.e., different L4 sequences may be combined with different L6 and L7 sequences and vice versa (not relevant for *P. aeruginosa*).

![Transmembrane topology models of the BamA β-barrel domains of *P. aeruginosa*, *P. fluorescens*, *P. putida*, and *P. syringae*. For each of the species groups, a BamA consensus sequence was derived by using all unique sequences present in GenBank. The crystal structure of *E. coli* BamA was used as a model (PDB [5EKQ](https://www.ebi.ac.uk/pdbe/entry/pdb/5EKQ)) to delineate β-strands. The weighted percentage of conservation for each amino acid residue, indicated as one block, is indicated according to relative abundance (see the color legend at the bottom right of each panel). The conserved VRGF motif is highlighted with residues inside in the blocks and is part of a residue stretch residing in the lumen of BamA (salmon-colored box). The different lengths for L4, L6, and L7 were derived from the observation that the corresponding sequences may differ greatly, depending on the species group of interest. Residues predicted to be exposed to the periplasm or extracellular medium are shown in smaller blocks. N and C specify the amino- and carboxy-terminal ends of the BamA barrel domains, respectively.](mbo0021837710004){#fig4}

LlpA is directed to a specific loop. {#s1.5}
------------------------------------

We previously evaluated a randomly chosen panel of *P. aeruginosa* strains for their susceptibility to pyocins L1 and L2 ([@B24]). Analysis of the different BamA β-barrel sequences of this strain set (*n* = 80) allowed us to retrieve the same L6 subtypes as obtained from reference sequences at similar frequencies ([Table 2](#tab2){ref-type="table"}), whereas polymorphism was barely present in L4 and L7 in the strain set, as expected (see above). Strikingly, PyoL1 essentially only killed strains sharing the same L6 sequence. Likewise, the subset of PyoL2-susceptible strains shared a single L6 sequence, different from the one present in PyoL1-killed strains, the sole noticed exception being *P. aeruginosa* CPHL 6750: this strain does not carry the prototypical PyoL2-targeted loop, although its L6 has several residues in common with the latter (I***ARD***AN***G***K***QI***P***GPDS***Q***GRYT*** versus the common PyoL2-targeted V***ARD***G\[N/K\]***G***N***QI***V***GPDS***K***GRYT***; the identical residues are shown in boldface italics in the sequences). *P. aeruginosa* strains with a BamA carrying any other L6 sequence all appeared resistant to lectin-like pyocins (*n* = 59 for PyoL1 and *n* = 67 for PyoL2). One exception was *P. aeruginosa* PA1255, which appeared resistant to PyoL2, despite carrying the corresponding bacteriocin-targeted L6 sequence. One possible explanation for this may be the absence of a suitable LPS binding partner. The crucial role of L6 was also evident for the BamAs from *P. aeruginosa* PAO1 and Br670 (used in the heterologous expression experiments), which are identical except for the hypervariable part of L6 ([@B43], [@B48]). *P. aeruginosa* strains with a *pyoL1* or *pyoL2* gene in their genome all feature L6 sequences different from the (sub)type that they target, as would actually be expected in order to avoid kin killing ([Table 2](#tab2){ref-type="table"}). Such built-in BamA-mediated autoimmunity provides an explanation for why LlpA production does not require a cognate immunity protein ([@B21], [@B25], [@B49]).

###### 

Hypervariable BamA L6 sequences in *P. aeruginosa* isolates and strains used in the test panel

  ----------------------------------------------------------------------------------------------------------------------------------------------------------
  **Hypervariable loop L6**\                                     Relative frequency (%)\   Test panel strains\   *P. aeruginosa*\                    
  **amino acid sequence**[^a^](#ngtab2.1){ref-type="table-fn"}   of sequence among:        susceptible to:       isolates encoding:                  
  -------------------------------------------------------------- ------------------------- --------------------- -------------------- ------- ------ -------
  PRSTPS***RAYKDGKIIPGPDER***\                                   37.3                      33.75                 0/27                 0/27    3/12   11/18
  ***GRYT***DPDQDPEAFGG                                                                                                                              

  PRSTPS***VARNPDGTPMKNQG***\                                    18.2                      26.25                 21/21                0/21    0/12   7/18
  ***PDSKGRYT***DPDQDPEAFGG                                                                                                                          

  PRSTPS***IARDANGKQIPGPDS***\                                   2.3                       1.25                  0/1                  1/1     0/12   0/18
  ***QGRYT***DPDQDPEAFGG                                                                                                                             

  PRSTPS***VARDG(N/K)GNQIVG***\                                  20.8                      15.0                  0/12                 11/12   9/12   0/18
  ***PDSKGRYT***DPDQDPEAFGG                                                                                                                          

  PRSTPS***RGEAEGGRPGTV***RDP\                                   17.2                      18.75                 0/15                 0/15    0/12   0/18
  DQDPEAFGG                                                                                                                                          

  Other                                                          4.2                       5.0                   0/4                  0/4     0/12   0/18
  ----------------------------------------------------------------------------------------------------------------------------------------------------------

Residues shown in boldface italics indicate the hypervariable sequence; nonpolymorphic (conserved) residues that are part of L6 are shown in lightface.

When we assessed the possible correlation of L6 sequence types and LlpA~BW11M1~ susceptibility in the *P. syringae* group, a similar observation as for *P. aeruginosa* was made, although this was evaluated for a smaller strain panel (*n* = 17). L6 sequences from the *P. syringae* group roughly segregated into four major types, two sets of partly related "long" and "short" loops, along with a significant number of more diverse L6 types that occurred at lower frequencies ([Table S1](#tabS1){ref-type="supplementary-material"}). Although bias appears to be present in our available *P. syringae* panel, all LlpA~BW11M1~-susceptible strains (*n* = 13) carry one of the short L6 cores (consensus sequence NGSKPGTLA), whereas the four LlpA~BW11M1~-resistant strains feature the longer L6 sequences. It should be emphasized that a number of additional polymorphic residues arise within the other surface-exposed loops of this LlpA~BW11M1~-susceptible strain set, and at this point it cannot be excluded that these may have more subtle quantitative effects toward bacteriocin inhibition, for example, by stabilizing LlpA docking.
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Relative frequencies of occurrence of hypervariable BamA L6 sequences in *P. syringae* group isolates and strains used in the test panel and LlpA~BW11M1~ susceptibility of strains in the respective set (highly conserved residues that are part of L6 are shown in gray). Download TABLE S1, DOCX file, 0.01 MB.
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Besides *P. syringae* group strains, LlpA~BW11M1~ was previously found to also target *Pseudomonas* strains assigned to other species groups, including *P. fluorescens* and *P. putida* ([@B25], [@B26], [@B49]). Although BamA polymorphism in the latter species groups is much higher and dominant loop signatures are more difficult to discern, strains (highly) susceptible to LlpA~BW11M1~ share an L6 signature sequence that well resembles the targeted short L6 type of *P. syringae*, despite highly divergent loops 4 and 7: for example, K***G***TN***PGT***IE in *Pseudomonas capeferrum* WCS358 ([@B50]), K***G***TN***PGTL***R in *P. fluorescens* BW11P2 ([@B51]), S***G***N***KPGTL***R in *P. mendocina* LMG 1223 ([@B52]), S***G***RN***PGT***QP in *P. viridiflava* LMG 2352 ([@B53]) (the boldface italicized residues are the common residues) ([Fig. S4](#figS4){ref-type="supplementary-material"}). Conversely, none of the *P. fluorescens* or *P. putida* strains that are LlpA~BW11M1~ resistant contain a sequence reminiscent of this more relaxed consensus motif (XGXX\[P\]GTXX; *n* = 6 versus *n* = 20 for the other L6 types). Overall, this *P. syringae* L6 subtype with the short sequence is more rare in strains of *P. fluorescens* (\~13% of isolates) and *P. putida* (\~27% of isolates), which may explain why fewer strains in these species groups are susceptible for LlpA~BW11M1~ ([@B26]). As expected, isolates encoding LlpA~BW11M1~ or a highly homologous sequence (\>97.5% amino acid identify) carry a *bamA* with an L6 type different than the one they target ([Table S2](#tabS2){ref-type="supplementary-material"}).
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Multiple sequence alignment of L6 sequences of BamAs from *Pseudomonas* spp. that are susceptible to LlpA~BW11M1~. Differential shading reflects the degree of sequence conservation. The hypervariable signature motif of LlpA~BW11M1~-susceptible isolates is boxed in blue. Download FIG S4, TIF file, 0.5 MB.
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Within the *P. fluorescens* group---the primary species group targeted by LlpA1 ([@B25], [@B26])---polymorphism appears even more complex. The L6 sequence retrieved in Pf0-1 was reminiscent of the longer subtypes retrieved in *P. syringae* and appeared in \~82% of the strains belonging to the *P. fluorescens* species group (PR***S***TP***SRG***XXX***TGN***X***GT***XX***D***\[S/P\]***D***\[N/Q\]***DPLP***FGG; boldface italics indicate \[hyper\]variable residues in common) ([Fig. 4](#fig4){ref-type="fig"}; [Table S1](#tabS1){ref-type="supplementary-material"}). Considering the high number of polymorphic residues in this loop set, no meaningful trend in possible LlpA1 receptiveness can be determined. As suggested above, LPS as a coreceptor may also be more critical for targeting strains in this species group.
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List of isolates encoding LlpA~BW11M1~ or a highly homologous sequence (\>97.5% amino acid identity; 0 to 2 different amino acid residues in amino-terminal lectin domains) and their corresponding BamA L6 amino acid sequence (nonpolymorphic \[conserved\] residues that are part of L6 in the *Pseudomonas putida* species group are shown in gray). Download TABLE S2, DOCX file, 0.01 MB.
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DISCUSSION {#s2}
==========

Our results demonstrated that LlpA parasitizes BamA and that one of its surface-exposed loops (L6) is key to bacteriocin target recognition. This moiety is the prime discriminant for target selectivity of L pyocins in *P. aeruginosa*. A strong correlation between L6 sequence subtype and susceptibility to a particular LlpA is also evident among other pseudomonads, such as those killed by LlpA of *Pseudomonas mosselii* BW11M1. Depending on the BamA-LlpA combination, an accessory role for the other exposed loops (L4/L7) cannot be excluded, given that L4 and L7 also display considerable sequence polymorphisms within different *Pseudomonas* species groups outside the more homogenous *P. aeruginosa* clade. In contrast to the key determinant L6, we expect that these BamA loops provoke only minor effects on relative susceptibility. Reasons for this are the observation that (i) BamA mutations in spontaneous LlpA-resistant mutants can only be linked to L6, (ii) several L1/L2 pyocin-targeted strains carry identical L4 and L7 sequences and thus only display surface-exposed polymorphism in L6, and (iii) LlpA~BW11M1~-targeted strains belonging to different species only share BamA sequence homology in the surface-exposed region L6, and not in L4 or L7. Given that (i) the amino-terminal lectin domain of lectin-like bacteriocins is responsible for strain selectivity ([@B21]) and (ii) highly homologous bacteriocins PyoL1 and PyoL2 display different target spectra and (the majority of) their differential residues form a localized patch in the amino-terminal lectin domain ([@B24]), our current hypothesis is that the amino-terminal domain mediates binding to BamA via the L6 loop, and this is facilitated and/or stabilized by interaction of the carboxy-terminal lectin domain of LlpA with specific carbohydrate moieties in LPS. The observation that some pseudomonads host two *bamA* genes is intriguing as well ([@B36]). Expression of both these genes possibly makes isolates susceptible to lectin-like bacteriocins with different target panel specificities. This may explain why *P. migulae* ZA 45.2 ([Fig. S3](#figS3){ref-type="supplementary-material"}) and some other strains belonging to the *P. fluorescens* species group ([@B26]) are killed by both LlpA~BW11M1~ and LlpA1.

The receptors of several modular bacteriocins, such as colicins (*E. coli*) and S-type pyocins (*Pseudomonas aeruginosa*), have been previously identified and typically function in the uptake of small molecules, such as vitamin B~12~ or iron-scavenging siderophores ([@B4], [@B5]). After receptor contact, bacteriocins are translocated across the outer membrane, either taking advantage of the receptor channel itself (energized by the Ton system) or via the trimeric OmpF porin (by usage of the Tol system). The dynamics of the latter process have been studied in more detail for colicin E9 of *E. coli* and involve major structural rearrangements of the bacteriocin to ensure threading through narrow pores of OmpF ([@B54]). More recently, the uptake process of pyocin S2 via the TonB-dependent iron transporter FpvAI was elucidated ([@B55]). Docking of this bacteriocin is achieved via structural mimicry where pyocin S2 attains a similar structure as the natural siderophore ligand of this receptor. Subsequently, the same conformational changes that would account for uptake of legitimate siderophores are induced, leading to unfolding and displacement of a transporter-occluding plug and hence transfer of the bacteriocin to the periplasm.

Contact-dependent growth inhibition (CDI) cassettes represent a different type of polymorphic toxin widespread among Gram-negative bacteria ([@B20], [@B56][@B57][@B58]). It requires a two-partner secretion system: CdiB is an outer membrane protein that transports the large effector protein CdiA, which is equipped with a toxin module at its carboxy terminus (CdiA-CT). Similar to modular bacteriocins, self-inhibition by the toxin is temporarily impeded by an immunity protein (CdiI). To date, several toxin activities of CdiA-CTs have been described, and a significant portion of these effectors display activities similar to colicins and pyocins (nuclease, pore forming) ([@B20], [@B56], [@B59]). For example, structural similarities were detected between a CDI toxin from *Enterobacter cloacae* and the rRNase domain from colicin E3 ([@B60]). A central region of CdiA accounts for target recognition and facilitates direct cell-to-cell contact ([@B61]). Several CDI receptors have been identified to date: the CdiA from *E. coli* EC536 interacts with OmpC and OmpF, whereas CdiA from *E. coli* STEC_O31 binds to the nucleoside transporter Tsx ([@B61]). Interestingly, BamA was previously identified as a CDI receptor as well (for CdiA from *E. coli* EC93) ([@B62]), and a specific contribution could be assigned to a combination of L6 and L7 ([@B63]). Although a link between loop polymorphism and receptor binding of CDI effectors can be observed, the structural details of the interaction between each of these partners remain elusive at this point.

A similar killing route as that followed by polymorphic toxins is unlikely to be followed by LlpAs. Lectin-like bacteriocins lack an obvious killing domain that needs to be translocated across the outer and/or inner membrane, and in addition, LlpA appears to be a very rigid molecule ([@B21], [@B22]): its two β-prisms are stabilized by conserved tryptophan triads, which are further rigidified by a number of intramolecular interactions. Extensive unfolding during translocation, as postulated for colicins and possibly some CdiAs, seems less plausible for LlpAs, and a "killing-upon-contact" mechanism can be envisaged that somehow interferes with the function of BamA, one of the few essential outer membrane proteins. Within this perspective, the lack of an obvious killer domain in lectin-like bacteriocins could point to a stress-activated killing system. In enterobacteria, the lipoprotein RcsF was previously shown to act as an envelope stress sensor, immediately interacting with BamA ([@B64], [@B65]). It remains unclear, however, whether a similar system is equally active in *Pseudomonas*.

It will be of particular interest to further explore the role of the carboxy-terminal β-hairpin extension of LlpAs. This stretch is pivotal for obtaining a functional bacteriocin, since a minor shortening (3-amino-acid deletion) results in loss of functionality ([@B21]). One possible mechanism of action that is compatible with the overall rigidity imposed by the dual β-prism architecture of LlpA may be that this part of LlpAs interferes with the gating dynamics of BamA, hampering insertion of unfolded outer membrane proteins ([@B37], [@B66][@B67][@B69]). In turn, this may lead to accumulation of unfolded polypeptides in the periplasm and a downstream response. This hypothesis is supported by the observation that L6, the loop selected by LlpAs, is rather rigid and positioned at the same side of BamA's lateral pore ([@B34]). Recently, it was also demonstrated that integration of membrane proteins is highly dependent on the interaction of a buried part of L6 and one of BamA's β-sheets in the barrel ([@B70]); a bacteriocin interaction may therefore also (structurally) interfere with the fine-tuning of this process. Future work will therefore be orientated toward unraveling the three-dimensional interaction of LlpA and BamA, in order to understand the nature of their protein-protein interaction. The direct interference with an essential protein(s) in the outer membrane, such as the BAM complex, is currently being explored as a novel antimicrobial strategy, for example, by designing peptides that actively interfere with the BAM machinery ([@B71], [@B72]) or peptidomimetics that selectively target β-barrel outer membrane proteins ([@B73]).

MATERIALS AND METHODS {#s3}
=====================

Strains, plasmids, and culture conditions. {#s3.1}
------------------------------------------

Bacterial strains and plasmids used in this study are listed in [Table S3](#tabS3){ref-type="supplementary-material"}. *E. coli* and *P. aeruginosa* strains were grown in lysogeny broth (MP Biomedicals) at 37°C. Other *Pseudomonas* strains were cultured in Trypticase soy broth (TSB; BD Biosciences) at 30°C. All cultures underwent shaking at 200 rpm. Media were solidified with 1.5% agar (Invitrogen). Media were supplemented with filter-sterilized ampicillin (100 to 800 µg/ml; Sigma-Aldrich), isopropyl β-[d]{.smallcaps}-1-thiogalactopyranoside (IPTG; 25 µg/ml; ForMedium), kanamycin (50 µg/ml; Sigma-Aldrich), tetracycline (15 to 150 µg/ml; Sigma-Aldrich), or gentamicin (15 to 45 µg/ml; TCI Europe) when required. Bacterial stocks were stored in the appropriate medium at −80°C in 25% (vol/vol) glycerol (VWR).
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Strains and plasmids used in this study. Download TABLE S3, DOCX file, 0.02 MB.
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Plasmids were propagated in *E. coli* TOP10F′ (Invitrogen). *E. coli* BL21(DE3) (Novagen) was used as a host for generating recombinant bacteriocins. Genomic DNA from *Pseudomonas* strains was collected with the Puregene Yeast/Bact kit B (Qiagen). Plasmid DNA was isolated using the QIAprep spin miniprep kit (Qiagen).

Expression and purification of lectin-like bacteriocins. {#s3.2}
--------------------------------------------------------

Plasmid construction and production of His-tagged LlpA bacteriocins were described previously ([@B21], [@B24], [@B26]). Briefly, overnight cell cultures of BL21(DE3) containing the plasmid of interest were subcultured in 500-ml Erlenmeyer flasks, with shaking. After the optical density (600 nm) reached 0.6, cultures were cooled to 16°C, supplemented with IPTG, and induced for an additional 16 h (overnight). The following day, cells were harvested by centrifugation (20 min, 5,000 × *g*), and pellets were frozen overnight at −20°C. Next, cells were resuspended in lysis buffer containing 300 mM NaCl (VWR International), 5 mM imidazole (Sigma-Aldrich), 50 mM Na~2~HPO~4~ (VWR International) at pH of 8.0. Subsequently, cells were lysed by sonication with a Branson digital sonifier (amplitude of 20%, 10 cycles of 30 s on/30 s off), and supplemented with 10 U/ml benzonase nuclease (0.5 h at 37°C; Sigma-Aldrich). Cell debris was removed by centrifugation (10,000 × *g*, 30 min), and the presence of recombinant protein in soluble fractions was confirmed by SDS-PAGE. The cell-free lysate was loaded on a 5-ml His-trap column (GE Healthcare), equilibrated with lysis buffer, using an Äkta purifier (GE Healthcare). Recombinant proteins were eluted over a 5 to 500 mM imidazole gradient, and bacteriocin fractions were selected by SDS-PAGE. Samples were dialyzed overnight (20 mM Tris-HCl, 200 mM NaCl; pH 7.5) and further polished by gel filtration on a Superdex 200 prep grade column (HiLoad 16/600; GE Healthcare). Recombinant bacteriocins were concentrated with Vivaspin filters (Sartorius Stedim). Protein concentrations were measured at 280-nm absorbance (Genesys 10S UV-Vis spectrophotometer; Thermo Scientific).

Antibacterial spot assay and isolation of mutants with altered LlpA sensitivity. {#s3.3}
--------------------------------------------------------------------------------

Strains of interest were grown overnight in LB or TSB (16 h, \~10^8^ to 10^9^ CFU/ml) supplemented with antibiotics and IPTG, if needed. Twenty-microliter aliquots of cell suspensions were added to 5 ml molten soft agar (0.5%) and poured on sterile plates containing the same medium to obtain cell lawns. Subsequently, 10-µl volumes of filter-sterilized purified recombinant bacteriocin (1 mg/ml) were spotted on top of the solidified lawn (dialysis buffer was used as a negative control). After drying, plates were incubated overnight. The following day, cell lawns were scored for the presence of halos (zones of growth inhibition), which are indicative of bacteriocin activity ([@B74]).

To obtain bacteriocin-resistant mutants, *P. fluorescens* Pf0-1 (15 independent cultures) and *P. aeruginosa* PAO1 (30 independent cultures) were grown for 48 h to obtain late-stationary-phase cultures. Cell lawns were made in a similar way as described above and supplemented with 50-µl spots of LlpA1 (on *P. fluorescens* Pf0-1) or PyoL1 (on *P. aeruginosa* PAO1) (5 mg/ml). One colony emerging per halo after 24 h of incubation time was selected, streaked to single colony, and verified for an altered (absent or highly tolerant) bacteriocin susceptibility phenotype. To exclude the presence of nonparental contaminants, genomic DNA of the isolates was collected and their *boxA* amplicon profile was compared with that of the wild type (BOX-PCR) ([@B75]).

Whole-genome sequencing and SNP detection. {#s3.4}
------------------------------------------

High-quality genomic DNA was isolated from overnight cultures of *P. fluorescens* Pf0-1 wild type and selected Pf0-1 mutants. Concentration and purity of the DNA were determined using Nanodrop analysis (Thermo Fisher Scientific), gel electrophoresis, and Qubit analysis (Thermo Fisher Scientific). Libraries were prepared at GeneCore (EMBL, Heidelberg) using the NEBNext kit with an average insert size of 200 bp. The DNA libraries were multiplexed and subjected to 100-cycle paired-end massive parallel sequencing with the Illumina HiSeq2000 system (GeneCore, EMBL, Heidelberg). CLC Genomics Workbench version 6.5.1 (Qiagen) was used for analysis of the sequences. Following quality assessment of the raw data, reads were trimmed using quality scores of the individual bases. The quality limit was set to 0.01, and the maximum allowed number of ambiguous bases was set to 2. Reads shorter than 15 bases were discarded from the set. After trimming, the average length of the remaining reads was 83.31 bp. The trimmed reads were mapped (mismatch cost of 2, insertion cost of 3, deletion cost of 3, length fraction of 0.8, similarity fraction of 0.8) to the *Pseudomonas fluorescens* Pf0-1 reference genome (NC_007492) using the CLC Assembly Cell 4.0 algorithm, yielding an average coverage of approximately 154×. Subsequently, mutations in all samples were identified using the CLC quality-based variant detection tool with default parameters. No mutations could be retrieved in *P. fluorescens* Pf0-1 in comparison to the reference genome.

Recombinant DNA methods. {#s3.5}
------------------------

Preparation of competent *E. coli* cells, heat shock transformation, and DNA gel electrophoresis were done using standard methods ([@B76]). The *bamA* genes from *P. aeruginosa* PAO1 ([AAG07036](https://www.ncbi.nlm.nih.gov/protein/AAG07036)), *P. aeruginosa* Br670 ([KSQ40041](https://www.ebi.ac.uk/ena/data/view/KSQ40041)), *P. fluorescens* Pf0-1 ([ABA72852](https://www.ncbi.nlm.nih.gov/protein/ABA72852)), and *P. savastanoi* pv. *glycinea* LMG 5066 ([KPX45010](https://www.ebi.ac.uk/ena/data/view/KPX45010)) were amplified by PCR with Q5 DNA polymerase (New England Biolabs) with a C1000 thermal cycler (Bio-Rad), using genomic DNA as a template. Amplicons were purified with the QIAquick PCR purification kit (Qiagen), digested, ligated in shuttle vector pJB3Tc20, and transformed to *E. coli* TOP10F′. Restriction (New England Biolabs) and ligation (T4 DNA ligase; Invitrogen) enzymes were used according to the supplier specifications. Plasmids with inserts were verified by sequencing (GATC Biotech, Constance, Germany) and subsequently introduced into *Pseudomonas* cells via electroporation. Electrocompetent cells were prepared by sucrose (Merck) treatment ([@B77]). After introduction of pCMPG6279 (pJB3Tc20 plasmid carrying *bamA*~*Br670*~) in *P. aeruginosa* PS186, the original plasmid carrying pMMB67EH with *bamA*~*PAO1*~ was cured by introducing pMMB67EH carrying a Gm^r^ cassette. Loss of *bamA*~*PAO1*~ was verified by PCR.

The *bamA* fragments encoding β-barrels in *P. aeruginosa* and *P. syringae* strains and the 16S rRNA fragments of *Pseudomonas* sp. strains VA 2.1, WCS365, and ZA 45.2 were amplified with Q5 DNA polymerase, purified, and sequenced. Primers used in this study are summarized in [Table S4](#tabS4){ref-type="supplementary-material"}.
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Primers used in this study. Download TABLE S4, DOCX file, 0.01 MB.
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Genome searches and multiple sequence analysis. {#s3.6}
-----------------------------------------------

BamAs and lectin-like bacteriocins in *Pseudomonas* genomes were identified using the National Center for Biotechnology (NCBI) nonredundant database for BLAST searches (sample date 1 July 2017). Sequences of BamAs from *P. fluorescens* Pf0-1 and *P. aeruginosa* PAO1, and also previously characterized LlpAs were used as search queries. Domains were predicted with Pfam ([@B78]). Multiple sequence alignments were created with MUSCLE ([@B79]), and gene synteny was explored with MAUVE 2.3.1 ([@B80]), implemented in Geneious v.7.1.9.

Structural modeling of β-barrel domains of *Pseudomonas* BamAs. {#s3.7}
---------------------------------------------------------------

The I-TASSER server ([@B81]) was used for structural modeling of the β-barrel domains of BamAs from *P. aeruginosa* PAO1 and *P. fluorescens* Pf0-1. Models were visualized with PyMOL.

Accession number(s). {#s3.8}
--------------------

The genome sequencing data set generated and analyzed in this study is available in the SRA repository of NCBI under accession number [SRP118490](https://www.ncbi.nlm.nih.gov/sra/?term=SRP118490) with BioProject number [PRJNA408273](https://www.ncbi.nlm.nih.gov/bioproject/408273).
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